Piper Sandler raised the firm’s price target on Amgen (AMGN) to $329 from $310 and keeps an Overweight rating on the shares. The firm notes the PSC Biopharma Research team recently co-hosted its ...

Amgen Inc. (NASDAQ:AMGN – Free Report) – Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to investors on Wednesday, February 5th.

COLUMBIA, Md. -- Three people were arrested in connection with the fatal shooting of a teen who was found dead in a car in Columbia, according to Howard County police. Officers found 17-year-old ...

Amgen Inc.'s Q4 2024 earnings beat expectations, with 11% YoY revenue growth and 13% EPS increase, showcasing robust performance for the company's growth strategy. Amgen's diversified portfolio ...

On Wednesday, Erste Group upgraded shares of biotechnology firm Amgen (NASDAQ:AMGN) from Hold to Buy. The upgrade was primarily attributed to Amgen's financial performance, which includes a higher ...

Less than a decade since it secured its first FDA approval for a biosimilar, Amgen’s portfolio of the copycat drugs is growing and making strong contributions to the company’s top line.

Shares of biotech company Amgen (NASDAQ:AMGN) jumped 5.3% in the morning session after the company reported strong fourth-quarter results. Amgen exceeded analysts' revenue expectations this ...

INDIANAPOLIS — Natasha Howard signed with the Indiana Fever to make one more title run. She’s hoping it happens this season. The two-time WNBA All-Star and the league’s 2019 Defensive Player of the ...

TikTok star Matt Howard temporarily made the decision to sleep separately from wife Abby Howard. “This is super embarrassing, but I’ve been sleeping in our walk-in closet for the past month ...

MariTide Phase 3 studies to begin in first half of year FDA places hold on AMG 513 obesity drug trial Amgen's Q4 earnings beat estimates, revenue up 11% Feb 4 (Reuters) - Amgen (AMGN.O), opens new ...

Amgen Inc.’s disclosed that US regulators paused the study of an early-stage obesity drug, a lucrative market the company is trying to crack. The Thousand Oaks, California-based drugmaker didn ...

Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS ...